Trending Market News
UK consumer spending rose 0.8% annually in May after declining 0.1% in April, driven by hot weather boosting clothing and summer goods sales, according to surveys from Barclays and the British Retail Consortium. However, travel spending fell 5.8% for a third consecutive month, reflecting consumer caution amid economic uncertainty from the Iran war.
- Retail sales increased 3.7% year-over-year in May, the largest gain since April 2025, with the BRC reporting growth in both food (3.9%) and non-food (3.5%) categories
- Travel spending declined sharply with airline spending down 12.9% annually, marking three consecutive months of decreases as consumers react to geopolitical uncertainty
- Despite the rebound, spending growth of 0.8% trails the 3% inflation rate, and two-thirds of consumers are making financial adjustments due to economic uncertainty
OpenAI has confidentially filed for an IPO with the SEC, positioning itself for what could be one of the largest public market debuts in history. The filing comes a week after rival Anthropic's confidential filing and days before Elon Musk's SpaceX begins trading. OpenAI, valued at $852 billion as of late March, is targeting a potential IPO as early as Q4 2025.
- OpenAI serves over 900 million weekly active ChatGPT users but has raised more than $180 billion in funding while still burning cash to secure compute infrastructure and train AI models
- Anthropic recently closed a funding round at a $900 billion valuation, exceeding OpenAI's $852 billion valuation and intensifying competition to go public first
- OpenAI is working with Goldman Sachs and Morgan Stanley on the filing and shifting focus internally by shuttering fringe projects to emphasize enterprise business and its Codex coding assistant
A Harvard study of 3,572 pregnancies found that unintentional use of GLP-1 drugs (like Ozempic, Wegovy, Zepbound, and Mounjaro) in early pregnancy does not significantly increase risks of adverse outcomes. While these medications are not recommended during pregnancy and guidelines advise stopping them 1-2 months before conception, the research provides reassurance for women who used them before discovering they were pregnant.
- The risk of non-live birth was 29.7% with continued GLP-1 use versus 27.1% without continuation, a difference not statistically significant
- The study included 1,467 women with type 2 diabetes and found no substantial increase in risks for low/high birth weight or major congenital malformations
- GLP-1 drugs can increase accidental pregnancy risk by improving fertility through weight loss and, particularly with tirzepatide, compromising oral contraceptive absorption
AstraZeneca reported that its experimental obesity pill, elecoglipron, achieved 10.5% weight loss after 26 weeks in a mid-stage trial, positioning the drugmaker to compete with Novo Nordisk and Eli Lilly in the rapidly growing weight-loss market. The once-daily pill will advance to late-stage trials after meeting primary endpoints in a study of 310 adults with obesity or overweight conditions.
- Patients on the highest dose (75 mg) lost 11.8% of body weight after 36 weeks, with 89% achieving at least 5% weight loss; this trails Novo's Wegovy pill (14% loss) and Lilly's Foundayo (12% loss) in effectiveness
- Most common side effects were gastrointestinal, including nausea (55% vs 20% placebo), constipation (41% vs 6%), and vomiting (27% vs 5%), though discontinuation rates remained low
- AstraZeneca acquired elecoglipron from China's Eccogene for up to $2 billion in late 2023 and plans to explore combinations with other medicines for obesity-related conditions like diabetes and heart disease
Nvidia CEO Jensen Huang declined Senator Elizabeth Warren's invitation to testify at a June 11 Senate Banking Committee hearing focused on AI, China, and U.S. technological dominance. Warren criticized the decision, stating the American people deserve public answers about Nvidia's China business and views on export controls. Huang offered to host Warren at Nvidia's headquarters instead, while her staff seeks an alternative time for him to speak in an open setting.
- The hearing will address American AI development, innovation, affordability, and U.S. technological dominance, with Nvidia sitting at the center of key questions on AI, economic competition, and national security
- Warren pointed to Huang's attendance at high-profile events, including a $1 million-per-head Mar-a-Lago dinner and meetings with Chinese President Xi Jinping, while declining congressional testimony
- Huang emphasized Nvidia's decade-long commitment to American AI leadership, noting the company delivered the first AI supercomputer to U.S. researchers over ten years ago
PAI Partners, a long-time private equity partner of Nestle SA, has withdrawn from the bidding process for Nestle's water business, which includes the Perrier brand, according to a Bloomberg News report. The development represents a setback in Nestle's efforts to divest its water operations. Reuters was unable to immediately verify the report.
- PAI Partners dropped out of bidding for Nestle's water business portfolio that includes the iconic Perrier brand
- PAI Partners has been described as a 'long-time private equity partner' of Nestle, suggesting a history of collaboration between the firms
- The withdrawal could complicate Nestle's divestiture plans for its water division, potentially narrowing the field of interested buyers
Airline CEOs at the IATA annual meeting in Rio de Janeiro sharply criticized jet engine manufacturers for persistent supply problems and costly delays. Engine shortages and grounded aircraft are expected to constrain airline operations for at least the next five years, with supply-chain disruptions creating $11 billion in additional costs for carriers. The criticism highlights a stark disconnect between engine makers' double-digit margin growth and the financial pain airlines are experiencing.
- United Airlines CEO called lack of engines the 'biggest constraint' for at least five years; LATAM Brasil has 12 planes grounded and Cathay Pacific's HK Express has half its A320 fleet grounded at any time
- IATA CEO noted engine makers have increased margins by double digits while airlines face $11 billion in added costs from supply-chain disruptions, calling out the 'paradox' in their contrasting financial performance
- Problems span multiple manufacturers including RTX's Pratt & Whitney (GTF engine issues affecting hundreds of A320neo aircraft), Rolls-Royce, and GE Aerospace, with airlines reporting higher-than-expected maintenance costs and reduced engine durability
The Pentagon added major Chinese tech companies including Alibaba, Baidu, BYD, and leading memory chipmakers CXMT and YMTC to its list of firms allegedly aiding China's military. The designation restricts future U.S. government contracts with these companies and signals caution to U.S. suppliers, though it does not impose formal sanctions. The move comes amid ongoing U.S.-China geopolitical competition and could heighten bilateral tensions.
- The list now includes China's top e-commerce, internet search, automotive, robotics (Unitree, RoboSense), and biotech (WuXi AppTec) firms, representing a broad sweep of Chinese technology companies
- Under new law, the Pentagon will be prevented from contracting and procuring from listed companies in coming years, though firms can petition for removal
- The update was released less than a month after President Trump's meeting with Xi Jinping in Beijing, and mirrors a briefly posted then withdrawn February list with the notable re-addition of chipmakers CXMT and YMTC
Amazon has signed a multibillion-dollar, multi-year deal with Corning to supply optical fiber for its expanding U.S. AI data centers. The agreement will create 1,000 jobs at Corning's North Carolina factories and represents the latest major contract for Corning following similar deals with Meta and Nvidia. Corning's optical fiber technology is critical for enabling fast connections between data centers and the AI computing infrastructure they house.
- Corning stock has more than doubled in 2026 and increased nearly sixfold since the end of 2023, driven by surging AI infrastructure demand
- The deal follows Corning's $3 billion agreement with Nvidia in May and $6 billion deal with Meta in January, positioning optical communications as the company's largest and fastest-growing business segment
- Amazon has committed $10 billion to new data centers in North Carolina and created over 26,000 jobs in the state through AWS investments
Yemen's Houthi rebels threatened to ban Israel-linked ships from the Red Sea following renewed Israeli attacks on Iran, raising fears of major energy disruptions. The threat is particularly significant because Iran's closure of the Strait of Hormuz since February has already forced Saudi Arabia to divert over 70% of its oil exports through the Red Sea port of Yanbu. Any sustained Houthi attacks on Red Sea shipping could trigger another severe energy crisis.
- Saudi Arabia now routes more than 70% of its normal daily crude exports through Red Sea port of Yanbu after Iran closed Strait of Hormuz on February 28, making this route critical for global energy markets
- Houthi source indicated blocking Israeli ships is 'a first step' with potential escalation to stop all vessels heading to Israel, similar to their 2023-2024 Gaza war campaign that disrupted global shipping and forced major carriers to reroute around Africa
- The Houthis have been relatively quiet in the current Iran conflict compared to other Iranian-aligned groups, possibly to preserve leverage, avoid antagonizing neighbor Saudi Arabia, or signal less commitment to Iran's security than Hezbollah and Iraqi militias
Eli Lilly's stock surged after presenting full data on retatrutide, its experimental obesity drug, at the American Diabetes Association meeting. The lower 4 mg dose achieved approximately 19% weight loss, matching the highest dose of Lilly's current blockbuster drug Zepbound, with comparable tolerability. Analysts view this as extending Lilly's leadership in the $200 billion+ obesity market despite the stock's 15% year-to-date decline.
- The 4 mg dose of retatrutide produced roughly 19% weight loss with tolerability comparable to Zepbound's highest dose, positioning it as a potential first-line treatment and next step for patients who have exhausted tirzepatide efficacy
- Analysts highlighted that Lilly's deep obesity portfolio demonstrates widening rather than narrowing leadership over competitors in the incretin/obesity market
- The obesity drug market is increasingly competing on tolerability, with drugmakers balancing efficacy against side effects and dosing simplicity to drive broader adoption
The FDA approved Pfizer's Hympavzi drug for preventing bleeding episodes in children and certain patients with hemophilia. The approval makes it the first non-factor therapy available for pediatric patients aged 6-11 and expands use to hemophilia A or B patients aged 12+ with inhibitors. The drug offers a more convenient subcutaneous administration alternative to frequent intravenous infusions.
- Hympavzi is the first non-factor therapy approved for children aged 6-11 with hemophilia, regardless of inhibitor status
- The drug is administered under the skin via auto-injector pen, replacing intravenous infusions often given multiple times weekly
- Late-stage trials showed Hympavzi significantly reduced the mean treated annualized bleeding rate in adults and adolescents 12+ with hemophilia A or B with inhibitors
The International Air Transport Association (IATA) projects global airline profits will drop by half in 2026 due to surging fuel costs triggered by the U.S.-Iran conflict that began in February. Jet fuel prices have spiked 70% year-over-year, adding a collective $100 billion to industry fuel bills and reducing net profits from $45 billion to $23 billion.
- Net profit margins are expected to fall from 4.2% in 2025 to 2.0% in 2026, with airlines still recovering from Covid-19 and Gulf region carriers most affected
- Jet fuel prices surged 103% in March compared to the previous month, with oil prices exceeding $100 per barrel following the Middle East conflict
- European carriers like Ryanair and Lufthansa are hedging fuel costs for summer 2026, with some airline executives warning of potential competitor failures if high prices persist
Meta has filed a federal court contempt order against Israeli spyware firm NSO Group for allegedly violating a permanent injunction. The injunction had previously barred NSO Group from targeting WhatsApp and its users. This legal action represents Meta's continued efforts to protect its messaging platform from surveillance tools.
- NSO Group allegedly violated a permanent injunction that prohibited it from ever targeting WhatsApp and its users
- Meta is seeking a contempt order through federal court to enforce the previously established legal restrictions
- The case highlights ongoing tensions between tech platforms and commercial spyware vendors over user privacy and security
The UK's competition regulator has launched an investigation into eBay's $1.2 billion acquisition of Depop, a Gen Z-focused fashion resale platform, from Etsy. The probe will examine potential competition concerns arising from the transaction. This regulatory scrutiny could delay or impact the completion of the deal.
- The acquisition is valued at $1.2 billion, representing a significant investment by eBay in the resale fashion market
- Depop targets Gen Z consumers and was being sold by online marketplace Etsy
- The UK Competition and Markets Authority's investigation will assess whether the deal reduces competition in the online fashion resale sector
U.S.-based Ingredion has agreed to acquire British food ingredients company Tate & Lyle for £2.7 billion ($3.6 billion). The deal will combine the two rivals to create a major player in the food and beverage ingredients sector.
- The acquisition values Tate & Lyle at £2.7 billion or $3.6 billion
- The combined entity will form a food and beverage ingredients major through the merger of the U.S. and U.K. companies
- The transaction represents a cross-border consolidation in the ingredients industry
Tencent Holdings is seeking to raise $4 billion through a dual-currency bond sale involving U.S. dollar and offshore yuan notes. This marks the company's first dollar bond issuance since April 2021, with calls to global investors beginning June 8 and potential launch on June 9. The proceeds will be used for general corporate purposes under Tencent's $30 billion global medium-term note programme.
- Dollar bonds will be offered in 10- and 20-year maturities, while offshore yuan bonds will have 10- and 30-year tenors, with expected ratings of A1 (Moody's), A+ (S&P), and A (Fitch)
- Tencent last raised $4.15 billion via dollar bonds in April 2021 and completed a 9 billion yuan ($1.3 billion) dim sum bond sale in September 2025 after a four-year hiatus
- S&P Global Ratings highlighted Tencent's low debt ratios and forecasts the company will maintain a net cash position over the next two years
Intesa Sanpaolo launched a takeover bid to acquire all of Monte dei Paschi di Siena (MPS) on June 8. The move represents a major consolidation effort in the Italian banking sector. This follows recent activity including Banco BPM's interest in merging with MPS to create Italy's second-largest bank.
- Intesa Sanpaolo announced a bid to acquire all of Monte dei Paschi di Siena, one of Italy's oldest banks
- The bid comes shortly after Banco BPM urged MPS to discuss a merger that would create Italy's No. 2 bank
- The transaction marks continued consolidation in Italian banking, with multiple institutions competing for strategic positioning
Nvidia CEO Jensen Huang and SK Group Chairman Chey Tae-won are expected to announce a cooperation plan between their companies on Monday, according to South Korean media reports. Huang confirmed to reporters on Sunday that an announcement with SK could be made the following day. The collaboration details remain undisclosed, with SK Hynix not immediately commenting on the report.
- The announcement follows a dinner meeting between Huang and several major South Korean business leaders, including SK Group and LG Group chairmen, held in Seoul on June 5
- SK Hynix, a major memory chip manufacturer and SK Group subsidiary, is a key supplier to Nvidia and would be the likely partner in any cooperation plan
- Huang confirmed plans for a Monday announcement with SK when speaking to reporters on Sunday, though specific details of the cooperation have not been revealed
US biotech company Incyte Pharma is nearing a deal to acquire blood disorder drug developer Star Therapeutics for up to $2 billion, according to a Financial Times report citing sources familiar with the matter. The acquisition would expand Incyte's portfolio in blood disorder treatments.
- Incyte will pay $1.25 billion upfront in cash to Star's venture capital backers
- An additional $750 million is contingent on achieving certain performance milestones
- The deal targets Star Therapeutics, a biotech focused on developing blood disorder treatments